机译:透明细胞肾细胞癌对免疫检查点疗法反应的基因组相关性
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA;
Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Bristol Myers Squibb, New York, NY 10154 USA;
Bristol Myers Squibb, New York, NY 10154 USA;
Bristol Myers Squibb, New York, NY 10154 USA;
MIT, Broad Inst, Cambridge, MA 02142 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Columbia Univ, Med Ctr, New York, NY 10032 USA;
Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA;
Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21287 USA;
Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA;
Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA;
Mayo Clin, Scottsdale, AZ 85259 USA;
Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA;
机译:梅尔克尔细胞癌的基因组景观和对免疫检查点抑制剂治疗的反应的临床生物标志物
机译:回复:劳伦斯·山顶,汤姆鲍尔斯,Michael Staehler等。 更新欧洲泌尿外科协会肾细胞癌:免疫检查点抑制是一种新的骨干,在第一线治疗转移性透明细胞肾细胞癌。 2019年EUR UROL; 76:151-6转移性肾细胞癌症的主动监测:缺少治愈机会?
机译:解开LGALS1作为潜在的免疫检查点和透明细胞肾癌抗PD1治疗的反应的预测因子
机译:用非等温方法研究人肾细胞癌细胞热疗过程中的损伤行为
机译:默克尔细胞多瘤病毒特异的T细胞反应,免疫逃逸机制和免疫疗法在默克尔细胞癌中的作用
机译:透明细胞肾细胞癌对免疫检查点疗法反应的基因组相关性
机译:梅尔克尔细胞癌的基因组景观和对免疫检查点抑制剂治疗的反应的临床生物标志物